edoxaban
Showing 1 - 25 of 56
Thrombosis, Venous, Cancer, Catheter Complications Trial in Beijing (Edoxaban)
Not yet recruiting
- Thrombosis, Venous
- +2 more
- Edoxaban
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Nov 20, 2023
CTEPH Trial in Fukuoka (Edoxaban, Warfarin Potassium, Warfarin Potassium )
Active, not recruiting
- CTEPH
- Edoxaban
- +3 more
-
Fukuoka, JapanKyushu University Hospital
Aug 30, 2022
Non-Valvular Atrial Fibrillation Trial in Beijing (Edoxaban)
Recruiting
- Non-Valvular Atrial Fibrillation
- Edoxaban
-
Beijing, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences
Jun 14, 2022
Routine Clinical Practice for Non-valvular Atrial Fibrillation
Completed
- Atrial Fibrillation
- Edoxaban
-
Hong Kong, Hong Kong
- +3 more
Aug 17, 2022
Mitral Valve Stenosis, Atrial Fibrillation, Stroke Trial in Korea, Republic of (Edoxaban, Warfarin)
Recruiting
- Mitral Valve Stenosis
- +3 more
- Edoxaban
- Warfarin
-
Seoul, Seocho-gu, Korea, Republic of
- +6 more
Sep 12, 2022
Routine Clinical Practice for Non-Valvular Atrial Fibrillation
Completed
- Atrial Fibrillation
- Edoxaban
-
Khon Kaen, Muang District, Thailand
- +5 more
May 5, 2022
SCAD, AMI Trial in Sao Paulo (ASA, Clopidogrel, Edoxaban)
Recruiting
- SCAD
- AMI
- ASA
- +2 more
-
Sao Paulo, BrazilInstituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Fac
Nov 4, 2021
Auricular Fibrillation Trial in Spain (Edoxaban)
Recruiting
- Auricular Fibrillation
- Edoxaban
-
Elche, Alicante, Spain
- +32 more
Feb 16, 2023
Anticoagulation in Venous Thromboembolism and Cancer
Active, not recruiting
- Neoplasms
- Embolism
- Apixaban
- +5 more
-
London, United KingdomPfizer Investigational Site
Nov 17, 2022
Edoxaban in Patients 80 Years of Age or Older With Nonvalvular
Recruiting
- Atrial Fibrillation
- Edoxaban
-
Ansan, Korea, Republic of
- +29 more
Apr 6, 2023
Atrial Fibrillation, Left Atrial Appendage Thrombosis Trial in Korea, Republic of (Edoxaban)
Recruiting
- Atrial Fibrillation
- Left Atrial Appendage Thrombosis
- Edoxaban
-
Daegu, Korea, Republic of
- +11 more
Mar 12, 2022
Oral Anti-coagulants in Fragile Percutaneous Endoscopic
Completed
- Atrial Fibrillation
- Edoxaban
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Oct 25, 2021
Anticoagulants in Patients With Venous Thromboembolism in Korea
Completed
- Venous Thromboembolism
- Parenteral anticoagulant
- +5 more
-
Seongnam-si, Korea, Republic of
- +1 more
May 20, 2022
Atrial Fibrillation Trial in Italy (Edoxaban)
Completed
- Atrial Fibrillation
- Edoxaban
-
San Benedetto Del Tronto, Ascoli Piceno, Italy
- +7 more
May 1, 2021
Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey
Active, not recruiting
- Atrial Fibrillation
- Edoxaban
-
Antalya, Alanya, Turkey
- +44 more
May 18, 2022
Aortic Stenosis Trial in Oslo (Acetylsalicylic acid, Apixaban, Rivaroxaban)
Recruiting
- Aortic Stenosis
- Acetylsalicylic acid
- +3 more
-
Oslo, Norway
- +1 more
Mar 23, 2022
Cardiac Disease Trial in Worldwide (Edoxaban, Standard of Care (SOC))
Completed
- Cardiac Disease
- Edoxaban
- Standard of Care (SOC)
-
Birmingham, Alabama
- +47 more
Jul 5, 2022
NOACs in Oral and Maxillofacial Surgery: Impact on
Recruiting
- Surgery, Oral
- +5 more
- Type of surgery
- +5 more
-
Helsingborg, Sweden
- +1 more
Apr 11, 2022
Acute Ischemic Stroke Trial in Seoul (Edoxaban)
Completed
- Acute Ischemic Stroke
- Edoxaban
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 9, 2020
Direct Oral Anticoagulants in UK Clinical Practice ForFirst
Completed
- Atrial Fibrillation
- Edoxaban
- +2 more
-
Glasgow, United Kingdom
- +7 more
Jul 15, 2022
Coagulation Disorder Trial in Groningen (VMX-C001, Placebo, Apixaban)
Recruiting
- Coagulation Disorder
- VMX-C001
- +4 more
-
Groningen, NetherlandsQPS Netherlands B.V.
Dec 7, 2021
Atrial Fibrillation, Anticoagulants and Bleeding Disorders Trial in Seoul (Edoxaban, Warfarin)
Completed
- Atrial Fibrillation
- Anticoagulants and Bleeding Disorders
- Edoxaban
- Warfarin
-
Seoul, Korea, Republic ofSamsung Medical Center
Jul 31, 2020